Table 1 Endpoints.
From: Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
Baseline | 24th week | Final Visit | |
|---|---|---|---|
SLEDAI (0–105), median (rank) | 14.5 (7.8-22.3) | 4.0 (2.0–6.0)** | 2.0 (0.0–4.0)** |
PGA (0–3), median (rank) | 2.8 (2.0–3.0) | 0.0 (0.0–1.0)** | 0.0 (0.0-1.0) |
Hospitalization, n (%) | 25 (54%) | 1 (2.3%)** | 2 (4%)** |